Seems a little confusion around this deal for @PoolbegPharma 🤔10 Jan 2025 13:57
For what it’s worth, here is my take….
I see some peoples strategy is to sell #POLB and buy Hookipa to get the CVR. This is an obvious strategy BUT in my opinion a potentially dangerous one!!
Hookipa is loss making, though it is clear that with the Poolbeg influence they are doing a massive headcount reduction. No way Hookipa could raise the 30m fundraise PIPE without the Poolbeg team and the Poolbeg deal on the table. If the Poolbeg deal doesn’t go ahead then Hookipa share price is likely to drop considerably lower than where it is now.
With me so far??!
Poolbeg have shown that they’re very effective at running their capital light model still having £10.1m cash 3 years post IPO and the management team have turned around loss making companies before like hVIVO.
I think the best route would to be not overly risky and simply wait a few weeks and invest in the $30m fundraise as a I expect most existing Poolbeg shareholders would be offered the possibility to participate.
By doing it this way, you are not exposed to the risk of the deal going ahead or not and you still see the benefits of 45% of the $400m+ milestone payments which stay with the combined company.
#Simples